丸美生物
(603983)
| 流通市值：97.44亿 | | | 总市值：97.44亿 |
| 流通股本：4.01亿 | | | 总股本：4.01亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,234,928,329.88 | 1,663,082,248.33 | 881,288,902.19 | 3,459,318,084 |
| 营业总成本 | 2,163,511,234.3 | 1,541,827,838.79 | 761,891,108.23 | 3,214,916,856.76 |
| 其他经营收益 | | | | |
| 营业利润 | 163,920,747.27 | 183,297,342.15 | 122,876,460.7 | 296,611,057.33 |
| 利润总额 | 163,502,858.15 | 182,837,793.18 | 123,226,746.62 | 295,731,444.58 |
| 净利润 | 145,336,230.34 | 156,955,422.13 | 100,997,752.2 | 246,742,825.83 |
| 每股收益 | | | | |
| 其他综合收益 | -78,790.24 | -265,302.03 | -24,389.15 | -22,246.12 |
| 综合收益总额 | 145,257,440.1 | 156,690,120.1 | 100,973,363.05 | 246,720,579.71 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,139,849,428.88 | 2,273,642,119.56 | 2,313,458,719.72 | 2,235,887,239.43 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,422,983,289.75 | 2,359,484,363.51 | 2,376,841,684.44 | 2,377,567,587.6 |
| 资产总计 | 4,562,832,718.63 | 4,633,126,483.07 | 4,690,300,404.16 | 4,613,454,827.03 |
| 流动负债: | | | | |
| 流动负债合计 | 1,107,614,397.34 | 1,170,252,760.28 | 1,177,205,446.12 | 1,198,807,998.54 |
| 非流动负债: | | | | |
| 非流动负债合计 | 29,009,408.44 | 25,223,703.62 | 20,518,103.88 | 20,471,583.62 |
| 负债合计 | 1,136,623,805.78 | 1,195,476,463.9 | 1,197,723,550 | 1,219,279,582.16 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,363,829,653.05 | 3,381,829,272.78 | 3,432,153,477.11 | 3,331,157,901.88 |
| 股东权益合计 | 3,426,208,912.85 | 3,437,650,019.17 | 3,492,576,854.16 | 3,394,175,244.87 |
| 负债和股东权益合计 | 4,562,832,718.63 | 4,633,126,483.07 | 4,690,300,404.16 | 4,613,454,827.03 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,289,732,495.9 | 1,756,014,205.95 | 930,399,940.57 | 3,998,479,620.31 |
| 经营活动现金流出小计 | 2,330,715,330.74 | 1,676,923,499.94 | 893,206,433.89 | 3,724,603,217.99 |
| 经营活动产生的现金流量净额 | -40,982,834.84 | 79,090,706.01 | 37,193,506.68 | 273,876,402.32 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 300,040,064.5 | 239,037,875.91 | 58,383,110.73 | 193,442,309.22 |
| 投资活动现金流出小计 | 215,969,887.15 | 129,342,129.59 | 102,559,880.66 | 507,377,767.2 |
| 投资活动产生的现金流量净额 | 84,070,177.35 | 109,695,746.32 | -44,176,769.93 | -313,935,457.98 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 575,118,841.94 | 405,494,253.05 | 122,193,293.33 | 1,437,822,791.35 |
| 筹资活动现金流出小计 | 678,600,310.65 | 398,211,945.57 | 135,979,845.26 | 2,035,556,308.49 |
| 筹资活动产生的现金流量净额 | -103,481,468.71 | 7,282,307.48 | -13,786,551.93 | -597,733,517.14 |
| 汇率变动对现金及现金等价物的影响 | -111,732.73 | -42,086.02 | -17,794.29 | -6,647.49 |
| 现金及现金等价物净增加额 | -60,505,858.93 | 196,026,673.79 | -20,787,609.47 | -637,799,220.29 |
| 期末现金及现金等价物余额 | 880,754,930.72 | 1,137,287,463.44 | 920,473,180.18 | 941,260,789.65 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 196,026,673.79 | - | -637,799,220.29 |
最新报告期：2026-11-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中金公司 | 徐卓楠,袁华远,黄蔓琪 | 0.47 | 0.50 | -- | 2026-11-08 |
| 长江证券 | 李锦,罗祎 | 0.76 | 0.88 | 0.98 | 2026-11-06 |
| 方正证券 | 周昕,谷寒婷 | 0.43 | 0.47 | 0.55 | 2026-11-05 |
| 国信证券 | 柳旭,张峻豪,孙乔容若 | 0.45 | 0.49 | 0.52 | 2026-11-05 |
| 长江证券 | 李锦,罗祎 | 0.76 | 0.88 | 0.98 | 2026-09-14 |